Vertex Pharmaceuticals, Inc. (VRTX)
542.62
-4.41
(-0.81%)
USD |
NASDAQ |
Nov 12, 16:00
543.51
+0.89
(+0.16%)
After-Hours: 07:32
Vertex Pharmaceuticals Total Liabilities (Quarterly) : 11.83B for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 11.83B |
| June 30, 2026 | 7.175B |
| March 31, 2026 | 7.122B |
| December 31, 2025 | 7.477B |
| September 30, 2025 | 7.544B |
| June 30, 2025 | 6.861B |
| March 31, 2025 | 6.384B |
| December 31, 2024 | 6.681B |
| September 30, 2024 | 6.609B |
| June 30, 2024 | 5.357B |
| March 31, 2024 | 5.371B |
| December 31, 2023 | 5.506B |
| September 30, 2023 | 5.213B |
| June 30, 2023 | 4.879B |
| March 31, 2023 | 4.542B |
| December 31, 2022 | 4.238B |
| September 30, 2022 | 3.677B |
| June 30, 2022 | 3.649B |
| March 31, 2022 | 3.349B |
| December 31, 2021 | 3.332B |
| September 30, 2021 | 3.088B |
| June 30, 2021 | 3.025B |
| March 31, 2021 | 3.135B |
| December 31, 2020 | 3.065B |
| September 30, 2020 | 3.168B |
| Date | Value |
|---|---|
| June 30, 2020 | 2.697B |
| March 31, 2020 | 2.432B |
| December 31, 2019 | 2.233B |
| September 30, 2019 | 2.261B |
| June 30, 2019 | 1.964B |
| March 31, 2019 | 1.820B |
| December 31, 2018 | 1.811B |
| September 30, 2018 | 1.686B |
| June 30, 2018 | 1.621B |
| March 31, 2018 | 1.522B |
| December 31, 2017 | 1.504B |
| September 30, 2017 | 1.395B |
| June 30, 2017 | 1.418B |
| March 31, 2017 | 1.264B |
| December 31, 2016 | 1.559B |
| September 30, 2016 | 1.401B |
| June 30, 2016 | 1.380B |
| March 31, 2016 | 1.372B |
| December 31, 2015 | 1.405B |
| September 30, 2015 | 1.357B |
| June 30, 2015 | 1.326B |
| March 31, 2015 | 1.168B |
| December 31, 2014 | 1.238B |
| September 30, 2014 | 1.250B |
| June 30, 2014 | 945.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Gilead Sciences, Inc. | 38.45B |
| Regeneron Pharmaceuticals, Inc. | 10.91B |
| Sionna Therapeutics, Inc. | 22.74M |
| Amgen, Inc. | 81.70B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.74B |
| Shareholders Equity (Quarterly) | 20.91B |
| Debt to Equity Ratio | 0.3099 |
| Current Ratio | 2.337 |
| Net Debt Paydown Yield | -0.75% |